Search Results - Robin Meng

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study by Rui Wang, Antoine Italiano, Shubham Pant, Johann De Bono, Todd M Bauer, Christophe Massard, Chia-Chi Lin, Roberto Iacovelli, Martin Gutierrez, Mansoor Saleh, Helen Lee, Gennaro Daniele, Paolo Andrea Zucali, Marielle Chiron, Bradley C Carthon, Robin Meng, Giovanni Abbadessa, Marcello Tucci, Wu-Chou Su, Alastair Greystoke, Ying-Chun Shen, Matteo Perrino, Yingwen Dong, Laure Loumagne, Lucie Lépine

    Published in Journal for ImmunoTherapy of Cancer (2022-01-01)
    Get full text
    Article


  2. 2

    S259: SAR444245, A NON-ALPHA IL2, RESCUES CHRONIC ANTIGEN- AND CAR-DRIVEN T-CELL DYSFUNCTION by Irtiza Sheikh, Ahyun Choi, Patrick Reville, Jared Henderson, Estela Rojas, Cuong Le, Chizitara Okwuchi, Robert Carrio, Nathan Pate, Katie Malley, Dinesh Bangari, Julie-Ann Gavigan, Chaomei Shi, Bing Liu, Yu-An Zhang, Tony Byers, Ingrid Sassoon, Margot Cucchetti, Rui Wang, Maria Agarwal, Giovanni Abbadessa, Robin Meng, Elamaran Meibalan, Laura Powers, James Cao, Xiaoyou Ying, Kelly Balko, Qunyan Yu, Jing Jiao, Virna Cortez-Retamozo, Sukhvinder Sidhu, Donald Shaffer, Xiangming LI, Michael Green

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


Search Tools: